ReWalk Robotics Aktie
WKN DE: A12BMB / ISIN: IL0011331076
13.03.2025 14:33:44
|
Lifeward Says FDA Grants FDA Clearance For Next-Gen ReWalk 7 Personal Exoskeleton
(RTTNews) - Medical technology firm Lifeward Ltd. (LFWD) announced Thursday that it has received 510(k) FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7.
The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury (SCI) to stand and walk again, includes a number of new features, as well as enhancements and upgrades.
Lifeward will begin sales of the ReWalk 7 in the United States as soon as the product is available.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ReWalk Robotics Ltdmehr Nachrichten
06.03.25 |
Ausblick: ReWalk Robotics legt Quartalsergebnis vor (finanzen.net) | |
11.11.24 |
Ausblick: ReWalk Robotics stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu ReWalk Robotics Ltdmehr Analysen
Aktien in diesem Artikel
ReWalk Robotics Ltd | 1,37 | -1,44% |
|